Dacarbazine (DTIC)

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
18032
Extended schedule, escalated dose Temozolomide versus Dacarbazine in Stage IV Metastatic Melanoma : A Randomized Phase III Study of the EORTC Melanoma Group
20051
The H10 EORTC/GELA/IIL randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma.
20012
BEACOPP (4 cycles escalated + 4 cycles baseline) versus ABVD (8 cycles) in stage III & IV Hodgkin's Lymphoma

Back to Protocol section